CLOV holder plans sale of 12,712 Class A shares

An affiliate of CLOV plans to sell 12,712 shares of its Class A common stock, with an aggregate market value of $59,492.16, through Morgan Stanley Smith Barney LLC around July 15, 2026 on Nasdaq.

Rhea-AI Filing Summary

An affiliate of CLOV plans to sell 12,712 shares of its Class A common stock, with an aggregate market value of $59,492.16, through Morgan Stanley Smith Barney LLC around July 15, 2026 on Nasdaq. These shares were acquired from the issuer as restricted stock units granted as compensation. Recent 10b5-1 sales by Jamie Reynoso over June–July 2026 include multiple Class A common stock transactions, such as 7,289 shares on June 11, 2026 and 6,350 shares on June 15, 2026.

Key Figures

Shares planned for sale: 12,712 shares Aggregate market value of planned sale: $59,492.16 Shares outstanding: 430,969,398 shares +4 more

7 metrics

Shares planned for sale 12,712 shares Planned sale of Class A common stock around July 15, 2026

Aggregate market value of planned sale $59,492.16 Aggregate market value of 12,712 Class A shares to be sold

Shares outstanding 430,969,398 shares Class A common stock outstanding per notice

10b5-1 sale on June 11, 2026 7,289 shares Class A common stock sold under 10b5-1 on 06/11/2026

Proceeds from June 11, 2026 sale $35,752.71 Aggregate amount for 7,289-share 10b5-1 sale on 06/11/2026

10b5-1 sale on June 15, 2026 6,350 shares Class A common stock sold under 10b5-1 on 06/15/2026

Proceeds from June 15, 2026 sale $29,273.5 Aggregate amount for 6,350-share 10b5-1 sale on 06/15/2026

Key Terms

Form 144, Restricted Stock Units, 10b5-1 Sales, Class A Common Stock

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Class A Common Stock | 07/15/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for Jamie Reynoso 1209 Orange Street Wilmington DE 19801"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Class A Common Stock financial

"Class A Common Stock | Morgan Stanley Smith Barney LLC 1 New York Plaza"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLOV Class A shares are planned for sale in this Form 144 notice?

A total of 12,712 shares of CLOV Class A common stock are planned for sale. The shares have an aggregate market value of $59,492.16 and are expected to be sold through Morgan Stanley Smith Barney LLC around July 15, 2026 on Nasdaq.

What is the approximate date of the planned CLOV stock sale?

The planned sale of CLOV Class A common stock is targeted for around July 15, 2026. The notice lists Morgan Stanley Smith Barney LLC as broker for the transaction and identifies Nasdaq as the stock exchange where the shares are expected to be sold.

How were the CLOV shares being sold under this Form 144 acquired?

The 12,712 CLOV shares were acquired from the issuer as restricted stock units. The acquisition is dated July 15, 2026 and is described as compensation, indicating the shares stem from an equity award rather than an open-market purchase.

What recent 10b5-1 sales of CLOV stock by Jamie Reynoso are disclosed?

The notice lists several 10b5-1 sales by Jamie Reynoso, including 7,289 shares on June 11, 2026 for $35,752.71 and 6,350 shares on June 15, 2026 for $29,273.5, along with additional sales on June 17, July 6, and July 8, 2026.

How many CLOV shares are outstanding according to this Form 144 disclosure?

The notice reports 430,969,398 shares of CLOV Class A common stock outstanding. This figure serves as a capital-structure reference point and is separate from the 12,712 shares covered by the planned sale described in the Form 144 notice.

Which broker is handling the planned CLOV share sale and on which exchange?

The planned sale of 12,712 CLOV Class A shares is listed through Morgan Stanley Smith Barney LLC. The transaction is expected to occur on the Nasdaq stock market, as specified in the securities information section of the Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/15/2026 - 05:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001839066
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clover Health Investments, Corp.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	2014322133
Name of Person for Whose Account the Securities are To Be Sold	Jamie Reynoso
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	12712	59492.16	430969398	07/15/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	07/15/2026	Restricted Stock Units	Issuer			12712	07/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for Jamie Reynoso 1209 Orange Street Wilmington DE 19801	Class A Common Stock	07/08/2026	2384	11157.12
10b5-1 Sales for Jamie Reynoso 1209 Orange Street Wilmington DE 19801	Class A Common Stock	07/06/2026	6226	32764.54
10b5-1 Sales for Jamie Reynoso 1209 Orange Street Wilmington DE 19801	Class A Common Stock	06/17/2026	2360	11275.61
10b5-1 Sales for Jamie Reynoso 1209 Orange Street Wilmington DE 19801	Class A Common Stock	06/15/2026	6350	29273.5
10b5-1 Sales for Jamie Reynoso 1209 Orange Street Wilmington DE 19801	Class A Common Stock	06/11/2026	7289	35752.71

144: Remarks and Signature

Remarks	The proposed sales reported represent shares to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The purpose of the proposed sales is to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the reporting person.
Date of Notice	07/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Peter J. Rivas as attorney-in-fact for Jamie Reynoso
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)